204 Users Online
Global Celadrin Supplements Market Segmentation by Form ( Capsules, Gel ), Celadrin Supplement in the form of Capsules is expected to be the highest revenue at a CAGR of over 7.2% from 2023 to 2033.
Newly-released Celadrin Supplements Market analysis report by Persistence Market Research reveals that global sales of Celadrin Supplements in 2022 were held at US$ 405 Million. With a 7.3% projected CAGR from 2023 to 2033, the market is expected to reach a valuation of US$ 887 Million by the end of the forecast period. Celadrin Supplement in the form of Capsules is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 7.2% from 2023 to 2033.
|
Attributes |
Details |
|
Global Celadrin Supplements Size (2023) |
US$ 438 Million |
|
Global Celadrin Supplements Size (2033) |
US$ 887 Million |
|
Global Celadrin Supplements CAGR (2023-2033) |
7.3% |
|
U.S Celadrin Supplements CAGR (2023 – 2033) |
6.2% |
|
Key Companies Covered |
|
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
As per the Celadrin Supplements Market research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the value of Celadrin Supplements increased at around 8.2% CAGR. With an absolute dollar opportunity of US$ 449 Million, the market is projected to reach a valuation of US$ 887 Million by 2033.
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized VersionCeladrin is a topical analgesic that can be bought without a prescription. The primary ingredient is menthol, and it also contains cetylated and esterified fatty acids. It is a lotion used to treat osteoarthritis, bruising, sprains, and other joint and muscle pains. Arthritis is the 3rd most raising condition after diabetes and dementia which is associated with disability.
There are around 100 types of arthritis. Osteoarthritis is one of the most common arthritis in which the soft tissue called cartilage that works as a protective layer between the joints degrades mostly due to the wear and tear of the body. Thus, it is a common condition in people aged above 50 years, though it may occur at a young age due to past joint injury.
Celadrin supplements are used to cure this condition. It is recommended for a person having arthritis, joint pain, or psoriasis. It is either in a form of capsules or gel which are available in retail stores as well as on online platforms.
According to the Centres for Disease Control and Prevention, more than 32.5 adults in the U.S. are suffering from osteoarthritis. It is estimated that 1 in 4 US adults have arthritis which accounts for about 54.4 million people. By 2040, it is projected that this number will reach 78 million.
Around 80% of elderly people who are 55 years of age and older may have osteoarthritis that is detectable on an X-ray. Around 60% of them reportedly exhibit symptoms. It is estimated that 240 million people worldwide experience osteoarthritis symptoms. Rheumatoid arthritis is another form of arthritis that affect nearly 14 million people worldwide. Compared to men, post-menopausal women have a high chance of getting knee osteoarthritis. The increasing number of arthritis patients will accelerate the growth of celadrin supplements demand.
North America had a market size of US$ 167.3 Million in 2022 and it has US$ 180.9 Million in 2023. It is projected that the market in North America will be worth US$ 366.3 Million by 2033.
Osteoarthritis is commonly found in older generation people. In Canada, there are more than 861 thousand people in the age group 85 and above which is more than twice the number in 2016. There is a 12% increase in this age group since 2016. Thus, with the increase in the aged population, the frequency and burden of disability caused by osteoarthritis are expected to rise in Canada as the population ages and grows. More than 3.9 million people are detected with osteoarthritis in Canada. These factors will have a significant effect on the market.
Sales Team
Client Partner
United States Celadrin Supplements Market Analysis:
The market in the United States is expected to grow to be worth US$ 285.7 Million with an absolute dollar growth of US$ 128.7 Million from 2033 to 2033. The market in the United States has grown at a CAGR of 6.7% from 2018 to 2022 and is expected to grow at a CAGR of 6.2% from 2023 to 2033.
Celadrin supplements are also used in the treatment of Psoriasis. Due to psoriasis, an immune-mediated illness, the body creates new skin cells more quickly-in days as opposed to weeks. People in the age group 15 to 35 years are likely to get affected by psoriasis. Around 8 million people are affected by psoriasis in the U.S.
United Kingdom Celadrin Supplements Unit Market Analysis:
The market in the United Kingdom is expected to grow to be worth US$ 45.6 Million with an absolute dollar growth of US$ 21.3 Million from 2023 to 2033. The market in the United Kingdom grew at a CAGR of 7.1% from 2018 to 2022 and is expected to grow at a CAGR of 6.5% from 2023 to 2033.
In the U.K. around 8.5 million people have osteoarthritis, whereas more than 10 million people suffer from back pain. Also, 1% of the population in the UK has rheumatoid arthritis, according to the most recent statistics from a 2020 study by the National Institute for Health and Care Excellence (NICE). Celadrin supplements are prominently used for pain relief. Thus, owing to this data the market will experience a rise in demand in the coming years.
China Celadrin Supplements Market Analysis:
In China, the market is expected to grow to be worth US$ 76.9 Million with an absolute dollar growth of US$ 42.2 Million. The market in the country has grown at a CAGR of 9.7% from 2018 to 2022 and is expected to grow at a CAGR of 8.3% from 2023 to 2033.
China has the largest older age population in the world, wherein around 254 million people in 2022 were in the age group 65 years and above. This number is expected to increase to 402 million by 2040 which will constitute about 28% of the population. In 2019, according to WHO, 75% of older people suffer from this non-communicable disease. As arthritis is common among the older age, thus for its cure there will be demand for Celadrin supplements.
Japan Celadrin Supplements Market Analysis:
The market in Japan is expected to grow to be worth US$ 64.9 Million with an absolute dollar growth of US$ 31.1 Million. The market in the country grew at a CAGR of 7.5% from 2018 to 2022 and is expected to grow at a CAGR of 6.7% from 2023 to 2033.
In Japan, aged people who belong to 65 years and over made up 36.2 million people in 2021, which was a record-high 28.9% of the total population. The older age population is significantly increasing in Japan. It has the highest senior population ratio globally. Due to this, the number of patients having osteoarthritis is also high in the country, thereby affecting the demand positively.
Which form of Celadrin Supplements is projected to Witness the Fastest Growth?
The capsule form of celadrin supplements is projected to witness the fastest growth as it has grown at a CAGR of 8% from 2018 to 2022 and is expected to grow at a CAGR of 7.2% from 2023 to 2033.
Celadrin tablets are composed of cetyl myristoleate, eicosapentanoic acid, and docosahexanoic acid. The celadrin pill consistently supports joint performance. It improves the general health of the structural system, encourages healing, and lowers discomfort. The demand for celadrin capsules is increasing owing to the increasing number of health issues related to joint and muscle pain.
Key players in the Celadrin supplements market are Now Foods, Ergomax, Ashland, Pacific Rainbow International Inc., RichesM Healthcare, Life Extension, Abbott Laboratories Incorporation, Pfizer Inc., Bayer AG, and Eli Lilly and Company.
Some of the recent developments in the Celadrin supplements market are:
By Form
By Application
By Sales Channel
By Region
The market is estimated to be valued at US$ 438 Million in 2023.
The market is expected to reach an US$ 887 million valuation in 2033.
The market registered a CAGR of 8.2% over the last 4 years.
The market is projected to witness a CAGR of 7.3% from 2023 to 2033.
Capsules are expected to garner a significant value share by 2023.
The market revenue through the arthritis application is expected to garner a significant value share by 2023.
The United States is projected to witness a market size of US$ 285.7 Million and is expected to grow at a 6.2% CAGR from 2023 to 2033.
The key players operating the market are Now Foods, Ergomax, Ashland, Pacific Rainbow International Inc., RichesM Healthcare, Life Extension, Abbott Laboratories Incorporation, Pfizer Inc., Bayer AG, and Eli Lilly and Company.
North America is projected to witness significant growth in the Celadrin supplements market from 2023 to 2033 and its market size will be US$ 366.33 Million.
